Skip to main content
. 2022 Jan 4;14(1):120. doi: 10.3390/pharmaceutics14010120

Figure 4.

Figure 4

Most used codelivery systems for combined therapies with PDT in cancer, including (A) polymeric nanoparticles (PNPs), (B) nanostructured lipid carriers (NLCs), (C) solid lipid nanoparticles (SLNs), (D) liposomes, (E) gold nanoparticles (AuNPs), and (F) hydrogels.